---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-122149"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T19:33:27.682267+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma receives Nasdaq delisting notice for equity-rule non-compliance

## Summary
- Nasdaq Staff notified Company on Nov 20, 2024 of non-compliance with $2.5M stockholders' equity requirement (Listing Rule 5550(b)(1)).
- Company self-reported equity shortfall and requested Nov 14 hearing solely on equity rule; bid-price compliance was regained on Oct 29.
- Awaiting determination from Nasdaq Hearings Panel; delisting remains a risk if plan not accepted.
- Previously disclosed bid-price non-compliance resolved by 10 consecutive closing bids above $1.00/share.

## SEC filing metadata
- accession: 0001104659-24-122149
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465924122149/0001104659-24-122149-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465924122149/tm2429248d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-122149
- JSON: https://secwatch.observer/filing/0001104659-24-122149.json
- Plain text: https://secwatch.observer/filing/0001104659-24-122149.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.